Crystal Watson

1.0k total citations
55 papers, 768 citations indexed

About

Crystal Watson is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Crystal Watson has authored 55 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 16 papers in Rheumatology. Recurrent topics in Crystal Watson's work include Multiple Sclerosis Research Studies (19 papers), Polyomavirus and related diseases (14 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Crystal Watson is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Polyomavirus and related diseases (14 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Crystal Watson collaborates with scholars based in United States, United Kingdom and Czechia. Crystal Watson's co-authors include Machaon Bonafede, Shravanthi R. Gandra, Kathleen M. Fox, Barbara H. Johnson, H.J. Gross, Nicole Princic, Vernon F. Schabert, David J. Harrison, Arie Barlev and George J Joseph and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Crystal Watson

53 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Crystal Watson United States	17	301	259	185	134	96	55	768
Adriana María Kakehasi Brazil	17	447 1.5×	233 0.9×	88 0.5×	172 1.3×	31 0.3×	102	1.0k
Axel Svedbom Sweden	19	188 0.6×	220 0.8×	131 0.7×	85 0.6×	93 1.0×	55	981
Mohammed A. Omair Saudi Arabia	13	245 0.8×	142 0.5×	234 1.3×	73 0.5×	39 0.4×	86	662
Blanca Hernández‐Cruz Spain	17	718 2.4×	275 1.1×	89 0.5×	263 2.0×	55 0.6×	53	955
Graham Davenport United Kingdom	10	606 2.0×	242 0.9×	161 0.9×	94 0.7×	16 0.2×	21	1.0k
T.K. Kvien Norway	18	797 2.6×	290 1.1×	138 0.7×	251 1.9×	26 0.3×	59	1.2k
Nicola Ughi Italy	17	281 0.9×	133 0.5×	203 1.1×	90 0.7×	14 0.1×	49	862
Ana Filipa Mourão Portugal	16	534 1.8×	273 1.1×	67 0.4×	271 2.0×	20 0.2×	58	983
Liam Martin Canada	17	476 1.6×	120 0.5×	107 0.6×	106 0.8×	28 0.3×	34	791
Alice Klinkhoff Canada	14	496 1.6×	185 0.7×	56 0.3×	162 1.2×	27 0.3×	30	806

Countries citing papers authored by Crystal Watson

Since Specialization

Citations

This map shows the geographic impact of Crystal Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crystal Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crystal Watson more than expected).

Fields of papers citing papers by Crystal Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crystal Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crystal Watson. The network helps show where Crystal Watson may publish in the future.

Co-authorship network of co-authors of Crystal Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Crystal Watson. A scholar is included among the top collaborators of Crystal Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crystal Watson. Crystal Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Crystal, et al.. (2023). Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021. Neurology and Therapy. 12(6). 1961–1979. 6 indexed citations

Wu, Ning, et al.. (2018). Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon. ClinicoEconomics and Outcomes Research. Volume 10. 723–730. 8 indexed citations

Foley, John, Kavita Nair, Timothy R. Vollmer, et al.. (2017). Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis. Patient Preference and Adherence. Volume 11. 1035–1048. 19 indexed citations

Watson, Crystal, et al.. (2017). Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany. ClinicoEconomics and Outcomes Research. Volume 9. 85–97. 1 indexed citations

Gross, H.J. & Crystal Watson. (2017). Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey. Neuropsychiatric Disease and Treatment. Volume 13. 1349–1357. 62 indexed citations

Cano, Stefan, Sophie Cleanthous, Patrick Marquis, et al.. (2015). Measuring Upper Limb Function In Multiple Sclerosis: Enhancing The Abilhand’s Performance. Value in Health. 18(3). A24–A24. 4 indexed citations

Johnson, Barbara H., Machaon Bonafede, & Crystal Watson. (2015). Direct Medical Burden And Readmission Rates Among Non-Elderly Patients With Acute Ischemic Stroke In The United States. Value in Health. 18(3). A139–A139.

Cano, SJ, Sophie Cleanthous, P. M. Marquis, et al.. (2015). Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12. Value in Health. 18(7). A709–A710. 1 indexed citations

Cano, Stefan, Sophie Cleanthous, Patrick Marquis, et al.. (2015). Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36. Value in Health. 18(7). A713–A713. 1 indexed citations

10.

Johnson, Barbara H., Machaon Bonafede, & Crystal Watson. (2015). Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients. CNS Drugs. 29(6). 503–510. 13 indexed citations

11.

Fisher, Maxine D., Crystal Watson, Kathleen M. Fox, Yen‐Wen Chen, & Shravanthi R. Gandra. (2013). Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care population. Current Medical Research and Opinion. 29(5). 561–568. 26 indexed citations

12.

Bonafede, Machaon, Barbara H. Johnson, Madé Wenten, & Crystal Watson. (2013). Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States. Clinical Therapeutics. 35(10). 1501–1512. 26 indexed citations

13.

Bonafede, Machaon, Barbara H. Johnson, & Crystal Watson. (2013). Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US. ClinicoEconomics and Outcomes Research. 6. 11–11. 13 indexed citations

14.

Chastek, Benjamin, Kathleen M. Fox, Crystal Watson, & Shravanthi R. Gandra. (2012). Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan. Advances in Therapy. 29(8). 691–697. 22 indexed citations

15.

Bonafede, Machaon, Kathleen M. Fox, Barbara H. Johnson, Crystal Watson, & Shravanthi R. Gandra. (2012). Factors Associated With the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study. Clinical Therapeutics. 34(2). 457–467. 25 indexed citations

16.

Bonafede, R. Peter, Douglas C. Pearson, Benjamin Chastek, et al.. (2011). CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING. Value in Health. 14(3). A1–A2. 4 indexed citations

17.

Schabert, Vernon F., et al.. (2011). Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States. Journal of Medical Economics. 15(2). 264–275. 44 indexed citations

18.

Watson, Crystal, et al.. (2010). Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis. Journal of Medical Economics. 13(2). 228–235. 9 indexed citations

19.

Hassall, Oliver, et al.. (1998). Glove usage and reporting of needlestick injuries by junior hospital medical staff.. PubMed. 80(6). 439–41. 16 indexed citations

20.

Calabrese, Joseph D., C.L. Bowden, Susan L. McElroy, et al.. (1997). Lamictal Monotherapy in the treatment of bipolar disorder. European Neuropsychopharmacology. 1002(7). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact